Thierry Le Chevalier Selected Research

Adjuvant Chemotherapy

07/2007	Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program.
09/2006	DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.
07/2005	Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
06/2005	Adjuvant chemotherapy in early-stage non-small cell lung cancer.
05/2005	Adjuvant chemotherapy in completely resected non-small-cell lung cancer.
03/2005	Should adjuvant chemotherapy become standard treatment in all patients with resected non-small-cell lung cancer?
10/2004	Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer.
01/2004	Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
01/2004	[Adjuvant chemotherapy in non-small cell lung cancer]

22	Small Cell Carcinoma 07/2008 - 03/2003
5	Lung Neoplasms (Lung Cancer) 07/2007 - 08/2003
4	Neoplasms (Cancer) 08/2007 - 06/2002
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2006
1	Adenocarcinoma 03/2005
1	Breast Neoplasms (Breast Cancer) 01/2005

4	Cisplatin (Platino)FDA LinkGeneric 07/2008 - 01/2004
4	gemcitabine FDA Link 08/2004 - 06/2002
3	Epidermal Growth Factor Receptor (EGF Receptor)IBA 01/2006 - 11/2003
3	pemetrexed (MTA)FDA Link 08/2004 - 06/2002
1	ixabepilone (BMS 247550)FDA Link 08/2007
1	epothilone B (EPO906)IBA 08/2007
1	PlatinumIBA 08/2007
1	P-GlycoproteinsIBA 07/2007
1	erlotinib (CP 358,774)FDA Link 10/2006
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2004
1	imatinib (Gleevec)FDA Link 12/2003